Streetbeat News

ALUR

Allurion Technologies Inc.

https://www.allurion.com

Industry

Medical - Devices

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Open

2.39

Mkt cap

14M

Volume

34K

High

2.44

P/E Ratio

-0.23

52-wk high

98.75

Low

2.37

Div yield

N/A

52-wk low

2.15

TD Cowen has initiated coverage on Allurion Technologies with a Buy rating and set a price target of $2. This suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:52 am

Allurion has published a meta-analysis demonstrating an average weight loss of 12.5% and significant metabolic health benefits across 2,107 patients in 11 studies. This could positively impact Allurion's market position and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:11 pm

Roth MKM has initiated coverage on Allurion Technologies with a Buy rating and set a price target of $2.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 3:59 pm

Allurion Technologies has received a written notice from the NYSE indicating non-compliance with continued listing standards. This notice could impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 9:31 pm

Allurion Technologies, Inc. (NYSE:ALUR) announced new data from a study showing significant weight loss in adolescents using the Allurion Program. The study involved 91 adolescents and reported an average weight loss of 13.1% over four months with no serious adverse events.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:03 pm

In Monday's pre-market session, several consumer discretionary stocks experienced significant movements. Notable gainers include Leslies, Forza X1, and MGO Global, while losers include SRIVARU Holding, Allbirds, and Ulta Beauty. Ulta Beauty's decline follows its Q2 earnings report released two days ago.

Portfolio Pulse from Benzinga Insights

September 02, 2024 | 12:05 pm

Chardan Capital has maintained a Buy rating on Allurion Technologies but has lowered the price target from $5 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:09 pm

Allurion Technologies, Inc. (NYSE:ALUR) received a notice from the NYSE for not meeting the continued listing standards, as its stock price averaged below $1.00 per share over a 30-day period. This notice does not result in immediate delisting.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:08 pm

Allurion Technologies shares are trading lower due to continued weakness following the company's weak FY24 revenue guidance reported yesterday.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 4:14 pm

Allurion Technologies has revised its full-year 2024 revenue guidance to $40 million-$45 million, down from the previous $60 million-$65 million, and below the $55 million estimate. The company expects a 10%-15% growth in procedure volume.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:04 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.